Virpax Pharmaceuticals, Inc. (VRPX)
Largest Insider Buys in Sector
VRPX Stock Price History Chart
VRPX Stock Performance
About Virpax Pharmaceuticals, Inc.
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a …
Insider Activity of Virpax Pharmaceuticals, Inc.
Over the last 12 months, insiders at Virpax Pharmaceuticals, Inc. have bought $0 and sold $0 worth of Virpax Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Virpax Pharmaceuticals, Inc. have bought $126,725 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,500 shares for transaction amount of $5,805 was made by Sendrow Jerrold () on 2022‑05‑24.
List of Insider Buy and Sell Transactions, Virpax Pharmaceuticals, Inc.
| 2022-05-24 | 4,500 0.0406% | $1.29 | $5,805 | -18.85% | ||||
| 2022-05-18 | Chief Executive Officer | 75,750 0.6516% | $1.34 | $101,505 | -24.06% | |||
| 2022-05-18 | 4,479 0.0392% | $1.36 | $6,107 | -24.06% | ||||
| 2021-11-22 | director | 3,900 0.0661% | $3.92 | $15,308 | -56.88% | |||
| 2021-11-18 | Chief Executive Officer | 25,125 0.4169% | $3.99 | $100,249 | -58.38% | |||
| 2021-02-17 | director | 3,500 0.0922% | $6.79 | $23,762 | -33.15% | |||
| 2021-02-17 | director | 100 0.0028% | $7.16 | $716 | -33.15% |
Insider Historical Profitability
| Mack Anthony P. | Chief Executive Officer | 252562 3.1228% | $0.35 | 2 | 0 | <0.0001% |
| Sendrow Jerrold | 9006 0.1114% | $0.35 | 2 | 0 | <0.0001% | |
| Floyd Eric | 8018 0.0991% | $0.35 | 1 | 0 | <0.0001% | |
| JACOB GARY S | director | 3500 0.0433% | $0.35 | 1 | 0 | <0.0001% |
| Jambulingam Thani | director | 100 0.0012% | $0.35 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Parallel Advisors, LLC | $4.00 | <0.01 | 1 | -92.86% | -$52.00 | <0.0001 |